A citation-based method for searching scientific literature

J W Olney, J W Newcomer, N B Farber. J Psychiatr Res 1999
Times Cited: 699







List of co-cited articles
1261 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Recent advances in the phencyclidine model of schizophrenia.
D C Javitt, S R Zukin. Am J Psychiatry 1991
18

Glutamate receptor dysfunction and schizophrenia.
J W Olney, N B Farber. Arch Gen Psychiatry 1995
17

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
J H Krystal, L P Karper, J P Seibyl, G K Freeman, R Delaney, J D Bremner, G R Heninger, M B Bowers, D S Charney. Arch Gen Psychiatry 1994
16

Glutamate and dopamine in schizophrenia: an update for the 21st century.
Oliver Howes, Rob McCutcheon, James Stone. J Psychopharmacol 2015
362
14



Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.
John E Lisman, Joseph T Coyle, Robert W Green, Daniel C Javitt, Francine M Benes, Stephan Heckers, Anthony A Grace. Trends Neurosci 2008
704
11

A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior.
M Carlén, K Meletis, J H Siegle, J A Cardin, K Futai, D Vierling-Claassen, C Rühlmann, S R Jones, K Deisseroth, M Sheng,[...]. Mol Psychiatry 2012
397
11

Animal models of schizophrenia.
C A Jones, D J G Watson, K C F Fone. Br J Pharmacol 2011
412
11

GABAergic interneuron origin of schizophrenia pathophysiology.
Kazu Nakazawa, Veronika Zsiros, Zhihong Jiang, Kazuhito Nakao, Stefan Kolata, Shuqin Zhang, Juan E Belforte. Neuropharmacology 2012
295
10

Antidepressant effects of ketamine in depressed patients.
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
10

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.
Pierre Paoletti, Camilla Bellone, Qiang Zhou. Nat Rev Neurosci 2013
10

Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes.
Juan E Belforte, Veronika Zsiros, Elyse R Sklar, Zhihong Jiang, Gu Yu, Yuqing Li, Elizabeth M Quinlan, Kazu Nakazawa. Nat Neurosci 2010
532
9

NMDA receptor and schizophrenia: a brief history.
Joseph T Coyle. Schizophr Bull 2012
250
9

Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
Kate Merritt, Alice Egerton, Matthew J Kempton, Matthew J Taylor, Philip K McGuire. JAMA Psychiatry 2016
195
9

Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology.
J M Stone, C Dietrich, R Edden, M A Mehta, S De Simoni, L J Reed, J H Krystal, D Nutt, G J Barker. Mol Psychiatry 2012
178
8



Mice with reduced NMDA receptor expression display behaviors related to schizophrenia.
A R Mohn, R R Gainetdinov, M G Caron, B H Koller. Cell 1999
776
8

Abnormal neural oscillations and synchrony in schizophrenia.
Peter J Uhlhaas, Wolf Singer. Nat Rev Neurosci 2010
8



Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.
Joanna C Neill, Samuel Barnes, Samantha Cook, Ben Grayson, Nagi F Idris, Samantha L McLean, Shikha Snigdha, Lakshmi Rajagopal, Michael K Harte. Pharmacol Ther 2010
365
7

The positive and negative syndrome scale (PANSS) for schizophrenia.
S R Kay, A Fiszbein, L A Opler. Schizophr Bull 1987
7

Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis.
Ethan G Hughes, Xiaoyu Peng, Amy J Gleichman, Meizan Lai, Lei Zhou, Ryan Tsou, Thomas D Parsons, David R Lynch, Josep Dalmau, Rita J Balice-Gordon. J Neurosci 2010
650
7


Subanesthetic doses of ketamine stimulate psychosis in schizophrenia.
A C Lahti, B Koffel, D LaPorte, C A Tamminga. Neuropsychopharmacology 1995
643
7



Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia.
David A Lewis, Allison A Curley, Jill R Glausier, David W Volk. Trends Neurosci 2012
646
7

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia.
C S Weickert, S J Fung, V S Catts, P R Schofield, K M Allen, L T Moore, K A Newell, D Pellen, X-F Huang, S V Catts,[...]. Mol Psychiatry 2013
152
7


The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia.
Samuel M Cohen, Richard W Tsien, Donald C Goff, Michael M Halassa. Schizophr Res 2015
129
7

Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase.
M Margarita Behrens, Sameh S Ali, Diep N Dao, Jacinta Lucero, Grigoriy Shekhtman, Kevin L Quick, Laura L Dugan. Science 2007
410
7


The neurodevelopmental hypothesis of schizophrenia, revisited.
S Hossein Fatemi, Timothy D Folsom. Schizophr Bull 2009
474
7


Glutamate receptor ion channels: structure, regulation, and function.
Stephen F Traynelis, Lonnie P Wollmuth, Chris J McBain, Frank S Menniti, Katie M Vance, Kevin K Ogden, Kasper B Hansen, Hongjie Yuan, Scott J Myers, Ray Dingledine. Pharmacol Rev 2010
7



Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.
Lawrence S Kegeles, Xiangling Mao, Arielle D Stanford, Ragy Girgis, Najate Ojeil, Xiaoyan Xu, Roberto Gil, Mark Slifstein, Anissa Abi-Dargham, Sarah H Lisanby,[...]. Arch Gen Psychiatry 2012
227
6

Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study.
Camilo de la Fuente-Sandoval, Pablo León-Ortiz, Mariana Azcárraga, Sylvana Stephano, Rafael Favila, Leonardo Díaz-Galvis, Patricia Alvarado-Alanis, Jesús Ramírez-Bermúdez, Ariel Graff-Guerrero. JAMA Psychiatry 2013
129
6

Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers.
Jean Théberge, Robert Bartha, Dick J Drost, Ravi S Menon, Ashok Malla, Jatinder Takhar, Richard W Neufeld, John Rogers, William Pavlosky, Betsy Schaefer,[...]. Am J Psychiatry 2002
293
6

Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive.
Elias Mouchlianitis, Michael A P Bloomfield, Vincent Law, Katherine Beck, Sudhakar Selvaraj, Naresh Rasquinha, Adam Waldman, Federico E Turkheimer, Alice Egerton, James Stone,[...]. Schizophr Bull 2016
97
6

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
6

De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia.
G Kirov, A J Pocklington, P Holmans, D Ivanov, M Ikeda, D Ruderfer, J Moran, K Chambert, D Toncheva, L Georgieva,[...]. Mol Psychiatry 2012
525
6

A polygenic burden of rare disruptive mutations in schizophrenia.
Shaun M Purcell, Jennifer L Moran, Menachem Fromer, Douglas Ruderfer, Nadia Solovieff, Panos Roussos, Colm O'Dushlaine, Kimberly Chambert, Sarah E Bergen, Anna Kähler,[...]. Nature 2014
897
6

The dysconnection hypothesis (2016).
Karl Friston, Harriet R Brown, Jakob Siemerkus, Klaas E Stephan. Schizophr Res 2016
224
6

Rethinking schizophrenia.
Thomas R Insel. Nature 2010
977
6

Parvalbumin neurons and gamma rhythms enhance cortical circuit performance.
Vikaas S Sohal, Feng Zhang, Ofer Yizhar, Karl Deisseroth. Nature 2009
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.